Clinical trials in Honduras: ethical considerations

Authors

  • Jhiamluka Solano Department of Internal Medicine, Royal Oldham Hospital, Greater Manchester, United Kingdom
  • Orlando Garner Department of Critical Care, Midland Memorial Hospital, Midland, Texas, United States
  • Jalileh García School of Geography and Environment, University of Oxford, Oxford, United Kingdom
  • Mary L. Vallecillo-Zúniga Department of Pathology, Brigham and Women´s Hospital, Harvard Medical School, Boston, Massachusetts, United States

DOI:

https://doi.org/10.5377/innovare.v11i3.15359

Keywords:

Clinical trials, Ethics, Honduras

Abstract

Clinical trials represent the penultimate step in the hierarchy of scientific evidence and are crucial in developing new therapies. Therefore, rigorous design and ethical considerations must be implicit in all scientific inquiry's construction and review process. During scientific research, the ethical component is crucial and must be prioritised over any other interest. When designing a study and in its subsequent evaluation, the ethics committee must independently assess the ethical justification of the study. In other words, the result of the ethical review must be framed using human rights standards, must be independent and complete, regardless of the country where the study is carried out.

Downloads

Download data is not yet available.
Abstract
167
HTML (Español (España)) 47
PDF (Español (España)) 226
HTML 10
PDF 69

Published

2022-12-08

How to Cite

Solano, J. ., Garner, O. ., García, J. ., & Vallecillo-Zúniga, M. L. . (2022). Clinical trials in Honduras: ethical considerations . Innovare: Revista De Ciencia Y tecnología, 11(3), 190–192. https://doi.org/10.5377/innovare.v11i3.15359

Issue

Section

Opinion